Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Blinded, Randomized Study of Gabapentin (Neurontin(R)) and Gabapentin Enacarbil (Horizant(TM)) in Restless Leg Syndrome

Trial Profile

Blinded, Randomized Study of Gabapentin (Neurontin(R)) and Gabapentin Enacarbil (Horizant(TM)) in Restless Leg Syndrome

Status: Discontinued
Phase of Trial: Phase IV

Latest Information Update: 04 Jul 2016

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Gabapentin (Primary) ; Gabapentin enacarbil (Primary)
  • Indications Restless legs syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Jun 2016 Status changed from recruiting to discontinued.
    • 11 Apr 2016 Planned End Date changed from 1 Oct 2015 to 1 Dec 2016.
    • 11 Apr 2016 Planned primary completion date changed from 1 Oct 2015 to 1 Dec 2016.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with a username/password associated to your organization’s account.
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Federated access using single sign-on credentials.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top